Literature DB >> 9925354

Effect of ischemic preconditioning on myocardial oxygen consumption during ischemia.

Z L Xu1, H Endoh, A Ishihata, E Takahashi, K Doi.   

Abstract

Ischemic preconditioning (IPC) in the heart may reduce myocardial energy demand. The present study was undertaken to examine changes in myocardial oxygen consumption (MVO2) during ischemia by IPC in Langendorff perfused rat hearts. We assessed MVO2 during ischemia from the measurement of mitochondrial cyt. aa3 redox state by a two-wavelength reflectance spectrophotometry where T(1/2), the time from the onset of ischemia to the point for half reduction of cyt. aa3, was assumed to represent MVO2. The heart was preconditioned by three cycles of 5 min ischemia plus 5 min reperfusion and then subjected to 30 min global ischemia followed by reperfusion for 30 min. The T(1/2) was significantly longer in the preconditioned heart (30 +/- 6 s, n = 10) than the control heart (14 +/- 5 s, n = 9, P<0.001), indicating a reduction of MVO2 during ischemic period by IPC. The prolongation of T(1/2) was evident after only one IPC episode. When the heart was perfused with high K+ solution to abolish MVO2 for contractions, we still found the prolongation of T1(1/2) in the preconditioned heart (116 +/- 12 s, n = 6) compared to the control heart (86 +/- 10 s, n = 6, P<0.01), suggesting that decrease in contractile activity may be, in part but not completely, responsible for the reduction of MVO2. In contrast, the prolongation of T(1/2) was completely abolished by administration of a NO synthase inhibitor N omega-nitro-L-arginine in the high K+ arrested heart, demonstrating involvement of NO in the reduction of MVO2, presumably by suppression of mitochondrial respiratory chain. In conclusion, IPC reduces MVO2 during ischemia. The reduction of MVO2 in the preconditioned heart may be accounted for by decreased contractile activity and by depression of respiratory chain by NO.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9925354     DOI: 10.1006/jmcc.1998.0771

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  3 in total

Review 1.  Nitric oxide: an emerging role in cardioprotection?

Authors:  R D Rakhit; M S Marber
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

2.  Ouabain triggers preconditioning through activation of the Na+,K+-ATPase signaling cascade in rat hearts.

Authors:  Sandrine V Pierre; Changjun Yang; Zhaokan Yuan; Jennifer Seminerio; Christian Mouas; Keith D Garlid; Pierre Dos-Santos; Zijian Xie
Journal:  Cardiovasc Res       Date:  2006-11-06       Impact factor: 10.787

3.  Ischemic preconditioning accelerates muscle deoxygenation dynamics and enhances exercise endurance during the work-to-work test.

Authors:  Kohei Kido; Tadashi Suga; Daichi Tanaka; Toyoyuki Honjo; Toshiyuki Homma; Satoshi Fujita; Takafumi Hamaoka; Tadao Isaka
Journal:  Physiol Rep       Date:  2015-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.